# Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients

> **NCT04135014** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 138 (estimated)

## Conditions studied

- Anxiety

## Interventions

- **DRUG:** Midazolam
- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam and Dexmedetomidine

## Key facts

- **NCT ID:** NCT04135014
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-25
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135014, "Combination With Intranasal Dexmedetomidine and Oral Midazolam for Premedication in Pediatric Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04135014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*